For comparison, Lilly's arch-rival in the weight-loss category, Novo Nordisk, is developing an oral formulation of ...

For comparison, Lilly's arch-rival in the weight-loss category, Novo Nordisk, is developing an oral formulation of ...

The move has thrilled people in the vaccine sceptic community, including Mary Holland, chief executive of Children's Health ...

Jazz Pharmaceuticals has become the first drugmaker to get FDA approval for a treatment for diffuse midline glioma with H3 ...

If a deal is confirmed and consummated, Novartis would claim ownership of a biotech that has raised something of a stir in ...

Accelerating C-level turnover: Executives, particularly those navigating complex global portfolios, are facing unprecedented ...

In Part Two, putting theory into practice is addressed.

The reduction in Bayer's workforce under turnaround chief executive Bill Anderson has reached around 12,000 – a fall of ...

Researchers at the University of Arizona recently studied a non-invasive technique that uses sound waves to stimulate ...

At HLTH Europe 2025 in Amsterdam, pharmaphorum Deep Dive editor Eloise McLennan sat down with Eugene Borukhovich (CEO, YourCoach Health), David Klein (CEO, Click Therapeutics), and Malin Johansson ...

Novo Nordisk's already depressed share price has fallen again this morning, despite reporting an 18% increase in sales in the ...

The joint information sharing agreement between the medicines regulatory authority and reimbursement agency was first ...